Nabriva Therapeutics plc (NBRVF)

Nabriva Therapeutics Revenue

Nabriva Therapeutics had revenue of $29.56M in the twelve months ending June 30, 2023, down -16.35% year-over-year. Revenue in the quarter ending June 30, 2023 was $2.24M, a -75.60% decrease year-over-year. In the year 2022, Nabriva Therapeutics had annual revenue of $36.94M with 27.82% growth.

• Revenue (ttm): $29.56M
• Revenue Growth: -16.35%
• P/S Ratio: 0.00
• Revenue / Employee: $757,872
• Employees: 39
• Market Cap: 323.00 USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	36.94M	8.04M	27.82%
Dec 31, 2021	28.90M	23.87M	474.80%
Dec 31, 2020	5.03M	-4.45M	-46.98%
Dec 31, 2019	9.48M	-175.00K	-1.81%
Dec 31, 2018	9.66M	4.34M	81.54%
Dec 31, 2017	5.32M	-1.16M	-17.94%
Dec 31, 2016	6.48M	2.72M	72.07%
Dec 31, 2015	3.77M	1.37M	57.09%
Dec 31, 2014	2.40M	-26.40M	-91.67%
Dec 31, 2013	28.80M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.